Wegovy weight loss results per week: a realistic week-by-week picture

Step 1: the first four weeks, settling in, not scaling up

Wegovy starts at 0.25mg, a dose whose job is tolerability rather than meaningful fat loss. Your prescriber holds you here for four weeks before moving upward. Most people notice little change on the scales in week one or two, and that is entirely expected. What is happening is that semaglutide (a GLP-1 receptor agonist) is beginning to slow gastric emptying and nudge appetite hormones. The nausea and mild digestive discomfort some people feel in this phase is a sign the medicine is active, not a sign something has gone wrong.

A question our prescribers hear regularly: "I'm two weeks in and nothing has happened, is it working?" The honest answer is that 0.25mg is not a therapeutic weight-loss dose. Significant weekly results tend to arrive once titration has progressed. Patience at this stage sets you up for the more meaningful changes ahead. If you want to understand the very earliest phase in more detail, the week-one experience page covers what to watch for and what to ignore.

Step 2: months two and three, when the weekly numbers start to move

Once the dose reaches 1.0mg and beyond, appetite suppression becomes more noticeable and most people begin to see genuine weekly losses. These are rarely uniform. A week of 0.8–1.0 kg might be followed by a week where the scales barely shift, then another productive week. Water retention, menstrual cycle, sodium intake and sleep all introduce noise. The weekly average across months two and three is usually the most encouraging part of the whole journey.

Clinical trial data give a broad benchmark: by around week 20 participants in STEP 1 had lost roughly half of their eventual total weight loss. That suggests the pace is front-loaded relative to the full 68-week curve, though individual variation is wide. For a closer look at what week five tends to look like in practice, the week-five results page pulls together the relevant figures. The two-week results page also helps set expectations for the very early phase before appetite changes kick in properly.

Step 3: maintenance dose and the longer arc

At 2.4mg (the standard maintenance dose) average weekly loss typically slows compared with the months immediately after titration. The body adapts. This is normal physiology, not failure. The STEP 1 trial's ~15% average reduction over 68 weeks works out at roughly 0.15–0.2 kg per week across the whole period, though the actual weekly distribution is uneven. Some weeks you lose more; some weeks nothing moves at all; occasionally weight ticks up before coming back down.

The MHRA's April 2026 approval of the 7.2mg single-dose Wegovy pen introduced a higher ceiling. Trial data at 7.2mg showed average weight loss of around 20.7% over 72 weeks, approaching the results seen with tirzepatide 15mg in head-to-head studies. Whether that higher dose is appropriate is a clinical decision made with your prescriber. For a broader look at how total outcomes compare across the full treatment period, the Wegovy results overview has the fuller picture.

One practical note: your pen arrives from our GPhC-registered pharmacy via DPD, tracked to your door in plain, unbranded packaging the next working day after dispatch, there is no identifying label that tells anyone what is inside.

What affects your weekly results, and what you can do about it

The trial averages describe populations, not individuals. Several factors shape where your weekly loss lands. Dose level is the most obvious: higher doses produce stronger appetite suppression. Beyond that, protein intake matters more than most people expect, eating adequate protein while in a calorie deficit helps preserve muscle, which keeps your metabolic rate from falling as fast. Hydration, sleep quality and stress levels all affect the number on the scales day to day, sometimes masking fat loss that is genuinely occurring.

Physical activity, particularly resistance training, does not dramatically accelerate weight loss on its own, but it does improve the composition of what you lose. People who add some form of strength work tend to keep more muscle and lose more fat as a proportion of total weight lost. The full timeline page covers how these factors interact across the whole treatment course. If you are weighing yourself daily, averaging across the week gives a far more reliable signal than any single morning reading.

Questions about cost are reasonable when you are committing to a treatment that takes months to reach its full effect. The Wegovy cost context page explains what legitimate private pricing looks like and what a headline price should (and often does not) include. The Wegovy overview covers licensing, eligibility and the clinical evidence in one place if you want the fuller picture before deciding.

If you are ready to find out whether Wegovy is clinically suitable for you, speak to our prescribers through a free consultation, reviewed the same day by a real clinician, with no waiting list.